The FDA approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (D-VRd) for patients with newly ...

The field of experimental oncology continues to grapple with the persistent challenge of improving cancer treatment outcomes. Despite decades of research ...

The LARA trial (NCT04699071), a multi-center, single-arm, phase 2 study, found that combining pembrolizumab (Keytruda) with ...

Manulife Philippines and Manulife China Bank Life have partnered with AC Health, a leading integrated healthcare network in the Philippines, to educate ...

By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a ...

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

A group of researchers says they have made a major breakthrough toward finding a cure for pancreatic cancer. They wrote in a ...

FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...

Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.